trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'destiny breast04', 'breast']
the 4 th from #asco22
destiny breast04
trastuzumab deruxtecan in previously treated her2-low advanced #breastcancer trastuzumab deruxtecan resulted in significantly longer pfs &amp;os chemo os 23.9 mo 17.5 mo pfs 10.1 5.4 mo 
Clinical Oncologist from Texas????Director of @OncoAlert ?? Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own??